Mark E Delaney

SVP & Chief Commercial Officer

Mark E Delaney (SVP & Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $1.5M of DGX (7,946 sh × $187.35, as filed), executed Nov 18 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.9M

shares × price, as filed

Last traded

Jul 28

Filed Jul 29

Median ADV $221.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

DGX

Quest Diagnostics Incorporated DGX · 0 buys · 3 sells 3 filings

Recent filings

DGXSALE Quest Diagnostics Incorporated View filing → $376K
1,600 sh × $235.18
Exec Jul 28
Filed Jul 29 · 5:04 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $1.5M
7,946 sh × $187.35
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $307K
1,748 sh across 2 lots
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET